IOVANCE BIOTHERAPEUTICS, INC. Accumulated Other Comprehensive Income
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Accumulated Other Comprehensive Income of $13.08 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $13.08M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $12.65M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $16.44M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $16.10M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $13.08M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $12.65M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $16.44M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $16.10M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $20.86M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $6.29M 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$1.05M 10-K · filed 2026-02-24 |
| 2024-09-30 | $16.24M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $526.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $116.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.53M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$9.10M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $325.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$126.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$902.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | -$2.04M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$2.70M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$2.34M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$601.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | -$5.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $33.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $96.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $19.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $155.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $317.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $912.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $220.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $861.86M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $854.60M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $138.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$42.00K 10-K · filed 2020-02-25 |
| 2018-09-30 | -$120.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | -$3.00K 10-Q · filed 2018-08-07 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-28 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 |
| 2017-03-31 | $2.00K 10-Q · filed 2017-05-03 |
| 2016-12-31 | $29.00K 10-K · filed 2018-03-12 |
| 2016-09-30 | $163.00K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $78.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $68.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $48.00K 10-K · filed 2017-03-09 |
| 2015-09-30 | $38.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $21.70K 10-Q · filed 2015-08-10 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |